This Health Economics, Policy and Value-Based Longevity Care session addresses economic and policy dimensions of aging and longevity interventions. Topics include cost-effectiveness analyses, budget impact, and value assessment of geriatric services, preventive programs, long-term care, and geroprotective therapies. Presentations will explore payment models, value-based care frameworks, and incentives for integrating geroscience-informed approaches into health systems. The track welcomes research on macroeconomic implications of population aging, labor market effects, and intergenerational equity. Policy analyses examining coverage decisions, regulation, and governance of longevity-related technologies are also encouraged. The goal is to inform sustainable, equitable policies that support extended healthspan and functional independence.
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom